side effects – SASHA: South Australian Sexual Health Awareness

Updated guidelines for PEP (Post-Exposure Prophylaxis) after non-occupational and occupational exposure to HIV 

2 Min Read

U

Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine (ASHM), June 2023 ASHM has updated the National Guidelines for Post-Exposure Prophylaxis (PEP) after non-occupational and occupational exposure to HIV . These guidelines outline the updated Australian recommendations for human immunodeficiency virus (HIV) post-exposure prophylaxis (PEP) following potential or known exposure...

Read on Read later

Major report on HIV in Australia released

By J Pope

In HIV

3 Min Read

M

Australian Research Centre in Sex, Health and Society at La Trobe University, December 2022 A major national survey of Australians living with HIV has revealed more than 70 per cent of people living with HIV report their health-related quality of life to be good. This is very close to the target set in the current National HIV Strategy of 75 per cent of people living with HIV reporting good...

Read on Read later

Monkeypox update: Your Questions Answered video with Dr Dr Vincent Cornelisse / Updated Clinical Guidance from ATAGI / Responding to MPX: GBM in Australia (Survey)

By J Pope

In Gay Lesbian & Bisexual Health, Sexually Transmitted Infections (STIs)

3 Min Read

M

MPX – Monkeypox – Your Questions Answered (video) Thorne Harbour Health, 26 Aug, 2022 Thorne Harbour Health’s Cal Hawk is joined by Dr Vincent Cornelisse to unpack the latest information we have about the current global outbreak of the monkeypox virus (MPXV) including what our communities can do now to reduce their risk. Vincent is a specialist in sexual health medicine and...

Read on Read later

What makes gay and bisexual men in Australia choose not to take PrEP?

By J Pope

In Gay Lesbian & Bisexual Health, HIV, Safer sex

1 Min Read

W

nam/aidsmap, 14 April 2022 Perceived irrelevance, lack of awareness, problems with access, side effects, negative social impacts, and concerns about lack of STI protection, effectiveness and adherence are the most common reasons for not using PrEP among gay and bisexual men in Australia. This is according to a study recently published in the journal Behavioral Medicine which analysed reasons for...

Read on Read later

New digital factsheets for Aboriginal and Torres Strait Islander communities

By J Pope

In Aboriginal Health, HIV

1 Min Read

N

Anwernekenhe National HIV Alliance (ANA) and ‘Australian Federation of AIDS Organisations (AFAO), June 2021 The Anwernekenhe National HIV Alliance (ANA) and AFAO are very excited to bring you these new digital factsheets for Aboriginal and Torres Strait Islander communities on PrEP, PEP, treatment as prevention, and HIV testing. Representatives from ANA and our other member organisations...

Read on Read later

Trans and cis women and men all have similar levels of PrEP drugs in blood

By J Pope

In Gender & Sex, HIV

1 Min Read

T

nam/aidsmap, 7 September 2020 A study in which 24 trans women and 24 trans men who were taking gender-affirming hormone therapy were directly observed to take a daily dose of the standard formulation of the HIV prevention medication PrEP found that the levels of the two PrEP drugs tenofovir and emtricitabine were similar to the levels seen in similar cis men and women, and were all above levels...

Read on Read later

Tagside effects